| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |